Oxaloacetate CFS™ – 90 Capsules, 500mg

AEO capsules are claimed to reduce fatigue in ME/CFS and Long COVID patients. They are manufactured to high quality standards.

• The description claims up to 33% reduction in fatigue for ME/CFS patients in 6 weeks.
• The description claims up to 47% reduction in fatigue for Long COVID patients in 6 weeks.
• The description claims a significant reduction of fatigue by an average of 25 to 35%.
• The description claims 40.5% of the oxaloacetate group were classified as 'enhanced responders' with an average fatigue reduction of 63%.
• The description claims improvements in both mental and physical fatigue.